Rare diseases
Investigational molecules
Locations
Back to Spain3 294 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
SpainA study of PM54 and pembrolizumab in adults with advanced cancer
SpainStudy of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin
SpainA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
SpainA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
SpainA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
SpainA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
SpainA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
SpainA study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations
SpainA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
SpainA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
SpainA study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
